US Export Opportunities & Tariff Insights Webinar
This webinar brings together key trade and regulatory experts to unpack recent changes impacting Australian medical technology companies seeking to enter or grow in the US market. With new tariffs and regulatory updates reshaping the landscape, this session will provide timely insights and practical pathways for navigating these shifts.
Background
The USA has traditionally been the first ‘go-to market’ for Australian early-stage, growth, and expansion-stage medical device companies. Aside from the sheer size and value of the US healthcare market, the 2005 US-Australia Free Trade Agreement (USFTA) facilitated trade in medical devices by reducing or eliminating tariffs, improving transparency in government procurement, and promoting regulatory cooperation between the US Food and Drug Administration (FDA) and the Australian Therapeutic Goods Administration (TGA). The FDA regulatory framework was relatively well understood in terms of various approval pathways.
Objective
- To provide up to date insights into the challenges for AU medical device export companies created by the new tariffs regime and changes to the FDA.
- To enable AU medical device export companies to explore alternative market entry and access pathways.
- Practical strategies for market access, entry, and manufacturing validation in the US.
Learn Outcomes
- How recent US tariff changes could impact your business
- Practical strategies to manage export regulations
- Key insights to unlock growth opportunities in the US market
This event is highly relevant for both emerging startups and established MedTech companies.
Featured Speakers
- Tara Booth, Assistant Secretary, US Trade Taskforce – Department of Foreign Affairs and Trade (DFAT)
- Rachel Howard, Trade Commissioner, New York – Austrade
- Marco Theobald - Registrar Corp
- Stuart Elliott, Executive Director – Planet Innovation
Free webinar for members and non-members.
Additional Information
Speaker Profiles
Tara Booth, Assistant Secretary, US Trade Taskforce – Department of Foreign Affairs and Trade (DFAT)
Tara leads DFAT’s work on US trade policy and is closely engaged in bilateral and multilateral economic negotiations, with a focus on maintaining access and competitive advantage for Australian industries.
Rachel Howard, Trade Commissioner, New York – Austrade
Rachel oversees Austrade’s operations in the US northeast region, supporting Australian exporters and investors. She has deep expertise in trade facilitation, international business strategy, and building cross-market partnerships.
Marco Theobald - Registrar Corp
Born in Germany and holds a Ph.D. in Biology/Genetics from the University of Giessen. Since joining Registrar Corp in 2009, Mr. Theobald has led a team of 20 regulatory specialists, overseeing FDA regulatory services for pharmaceuticals, medical devices, radiation-emitting products, and cosmetics. As of January 2025, he has transitioned into the role of Principal Regulatory Specialist for Medical Devices and Drugs at Registrar Corp.
Stuart Elliott, Executive Director – Planet Innovation
Stuart is a co-founder of Planet Innovation, a leading healthtech innovation and commercialisation company. He works with global MedTech companies to bring medical devices from concept to market, with strong experience in US regulatory and manufacturing environments.
